Stay updated on Dociparstat Sodium with Standard Induction in AML Clinical Trial

Sign up to get notified when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dociparstat Sodium with Standard Induction in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays the completed Phase 2 study record for dociparstat sodium combined with standard induction therapy for acute myeloid leukemia, including study methods, measured outcomes, participant criteria, and locations. It also provides links to the study protocol and statistical analysis plan.
    Difference
    74%
    Check dated 2026-11-11T01:18:45.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:34:59.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the terminology transition from “AI” to “SI” appears above the page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:18:02.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:16:16.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    - The page now renders a 403 Forbidden error with a minimal header and a Home link, replacing the previously visible study content and navigation.
    Difference
    21%
    Check dated 2026-09-23T00:22:51.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, indicating a version update of the page or its underlying system. This change does not alter study data, eligibility criteria, outcomes, or any user-facing content.
    Difference
    0.0%
    Check dated 2026-09-15T23:44:14.000Z thumbnail image

Stay in the know with updates to Dociparstat Sodium with Standard Induction in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.